HEADER TRANSFERASE 26-JAN-16 5HTI TITLE CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH LXM108 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS C-MET INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Q.F.LIU,Y.C.XU REVDAT 2 27-SEP-17 5HTI 1 REMARK REVDAT 1 01-FEB-17 5HTI 0 JRNL AUTH Y.C.XU,Y.LONG JRNL TITL CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH JRNL TITL 2 LXM108 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.28 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 38060 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.250 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.5000 - 3.9970 0.99 2744 153 0.1656 0.1871 REMARK 3 2 3.9970 - 3.1735 1.00 2643 145 0.1779 0.1904 REMARK 3 3 3.1735 - 2.7726 1.00 2611 146 0.1948 0.2323 REMARK 3 4 2.7726 - 2.5192 1.00 2591 144 0.1898 0.2084 REMARK 3 5 2.5192 - 2.3387 1.00 2581 143 0.1732 0.1878 REMARK 3 6 2.3387 - 2.2009 1.00 2587 143 0.1772 0.2387 REMARK 3 7 2.2009 - 2.0907 1.00 2568 142 0.1818 0.2063 REMARK 3 8 2.0907 - 1.9997 1.00 2557 143 0.1847 0.1938 REMARK 3 9 1.9997 - 1.9227 0.99 2551 141 0.1874 0.2248 REMARK 3 10 1.9227 - 1.8564 1.00 2546 141 0.1783 0.2438 REMARK 3 11 1.8564 - 1.7984 1.00 2548 141 0.1804 0.2023 REMARK 3 12 1.7984 - 1.7470 1.00 2552 142 0.1861 0.2231 REMARK 3 13 1.7470 - 1.7010 1.00 2545 140 0.1857 0.2390 REMARK 3 14 1.7010 - 1.6595 0.96 2436 136 0.1921 0.2360 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2423 REMARK 3 ANGLE : 1.446 3289 REMARK 3 CHIRALITY : 0.261 363 REMARK 3 PLANARITY : 0.005 411 REMARK 3 DIHEDRAL : 13.211 887 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HTI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000217687. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38131 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 10.80 REMARK 200 R MERGE FOR SHELL (I) : 0.30700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4MXC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-11% PEG5000MME, 11% ISOPROPANOL, REMARK 280 0.1M HEPES PH 7.1, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.44700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.72450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.27850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.72450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.44700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.27850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1028 REMARK 465 GLY A 1029 REMARK 465 SER A 1030 REMARK 465 SER A 1031 REMARK 465 HIS A 1032 REMARK 465 HIS A 1033 REMARK 465 HIS A 1034 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 HIS A 1037 REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1061 OE1 REMARK 470 GLU A1150 CG CD OE1 OE2 REMARK 470 PHE A1290 CE1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A1172 4.49 -69.28 REMARK 500 ARG A1203 -14.93 78.70 REMARK 500 ASP A1204 49.52 -142.80 REMARK 500 ASP A1231 41.86 75.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1714 DISTANCE = 6.43 ANGSTROMS REMARK 525 HOH A1715 DISTANCE = 6.50 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 66L A 1401 DBREF 5HTI A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 5HTI MET A 1028 UNP P08581 INITIATING METHIONINE SEQADV 5HTI GLY A 1029 UNP P08581 EXPRESSION TAG SEQADV 5HTI SER A 1030 UNP P08581 EXPRESSION TAG SEQADV 5HTI SER A 1031 UNP P08581 EXPRESSION TAG SEQADV 5HTI HIS A 1032 UNP P08581 EXPRESSION TAG SEQADV 5HTI HIS A 1033 UNP P08581 EXPRESSION TAG SEQADV 5HTI HIS A 1034 UNP P08581 EXPRESSION TAG SEQADV 5HTI HIS A 1035 UNP P08581 EXPRESSION TAG SEQADV 5HTI HIS A 1036 UNP P08581 EXPRESSION TAG SEQADV 5HTI HIS A 1037 UNP P08581 EXPRESSION TAG SEQRES 1 A 319 MET GLY SER SER HIS HIS HIS HIS HIS HIS GLY ASP SER SEQRES 2 A 319 ASP ILE SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE SEQRES 3 A 319 ASP LEU SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL SEQRES 4 A 319 GLN HIS VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS SEQRES 5 A 319 PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL SEQRES 6 A 319 TYR HIS GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE SEQRES 7 A 319 HIS CYS ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE SEQRES 8 A 319 GLY GLU VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET SEQRES 9 A 319 LYS ASP PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY SEQRES 10 A 319 ILE CYS LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU SEQRES 11 A 319 PRO TYR MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG SEQRES 12 A 319 ASN GLU THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY SEQRES 13 A 319 PHE GLY LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SEQRES 14 A 319 SER LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 15 A 319 CYS MET LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP SEQRES 16 A 319 PHE GLY LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SEQRES 17 A 319 SER VAL HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS SEQRES 18 A 319 TRP MET ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR SEQRES 19 A 319 THR LYS SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP SEQRES 20 A 319 GLU LEU MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL SEQRES 21 A 319 ASN THR PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG SEQRES 22 A 319 ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR SEQRES 23 A 319 GLU VAL MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET SEQRES 24 A 319 ARG PRO SER PHE SER GLU LEU VAL SER ARG ILE SER ALA SEQRES 25 A 319 ILE PHE SER THR PHE ILE GLY HET 66L A1401 43 HETNAM 66L N-[3-FLUORO-4-({7-[2-(MORPHOLIN-4-YL)ETHOXY]-1,6- HETNAM 2 66L NAPHTHYRIDIN-4-YL}OXY)PHENYL]-N'-(4-FLUOROPHENYL) HETNAM 3 66L CYCLOPROPANE-1,1-DICARBOXAMIDE FORMUL 2 66L C31 H29 F2 N5 O5 FORMUL 3 HOH *215(H2 O) HELIX 1 AA1 ASP A 1054 LEU A 1058 5 5 HELIX 2 AA2 ASN A 1059 HIS A 1068 1 10 HELIX 3 AA3 GLY A 1072 SER A 1074 5 3 HELIX 4 AA4 ASP A 1117 LYS A 1132 1 16 HELIX 5 AA5 ASP A 1164 ASN A 1171 1 8 HELIX 6 AA6 THR A 1177 LYS A 1198 1 22 HELIX 7 AA7 ALA A 1206 ARG A 1208 5 3 HELIX 8 AA8 PHE A 1223 ARG A 1227 5 5 HELIX 9 AA9 PRO A 1246 MET A 1250 5 5 HELIX 10 AB1 ALA A 1251 GLN A 1258 1 8 HELIX 11 AB2 THR A 1261 THR A 1278 1 18 HELIX 12 AB3 ASN A 1288 PHE A 1290 5 3 HELIX 13 AB4 ASP A 1291 GLN A 1298 1 8 HELIX 14 AB5 PRO A 1309 TRP A 1320 1 12 HELIX 15 AB6 LYS A 1323 ARG A 1327 5 5 HELIX 16 AB7 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 5 LEU A1076 ARG A1086 0 SHEET 2 AA1 5 GLY A1090 LEU A1098 -1 O VAL A1092 N ILE A1084 SHEET 3 AA1 5 LYS A1104 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O VAL A1155 N LYS A1110 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N CYS A1146 O LEU A1154 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SITE 1 AC1 22 ILE A1084 VAL A1092 ALA A1108 LYS A1110 SITE 2 AC1 22 GLU A1127 MET A1131 PHE A1134 LEU A1140 SITE 3 AC1 22 LEU A1157 PRO A1158 TYR A1159 MET A1160 SITE 4 AC1 22 LYS A1161 GLY A1163 LEU A1195 MET A1211 SITE 5 AC1 22 VAL A1220 ALA A1221 ASP A1222 PHE A1223 SITE 6 AC1 22 HOH A1574 HOH A1604 CRYST1 42.894 80.557 91.449 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023313 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012414 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010935 0.00000 MASTER 286 0 1 16 7 0 6 6 0 0 0 25 END